Stay updated on Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page
- Check7 days agoChange DetectedA new 'Study Status' entry was added to the record history on 2026-02-17, and a deletion was recorded on 2025-08-13.SummaryDifference0.3%

- Check14 days agoChange DetectedThe history shows an addition of Revision: v3.4.2 and deletions of notices including a government funding notice and an earlier Revision: v3.4.1, reflecting routine maintenance. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check21 days agoChange DetectedA site-wide government funding status notice was added and the page revision updated to v3.4.1, replacing v3.4.0.SummaryDifference0.6%

- Check28 days agoChange DetectedAdds a glossary display and color-coded highlights for edits (green for additions, red for deletions) with explanatory notes. Introduces No FEAR Act data and updates the revision to v3.4.0 (replacing v3.3.4).SummaryDifference0.8%

- Check42 days agoChange DetectedA new revision entry (v3.3.4) was added and the previous revision (v3.3.3) was removed, updating the study record history.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page footer now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 items were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.